Our latest blog posts

A recent study from Great Ormond Street Hospital suggests that commonly prescribed nitrogen scavengers for Urea Cycle Disorders (UCD) may contribute to Branch Chain Amino Acid (BCAA) depletion, highlighting the need for a balanced approach that optimizes protein intake and considers alternative treatments.

Organoid electrophysiology is providing pharmaceutical and biotech companies with human-relevant models for testing drug efficacy, modeling diseases, and reducing reliance on animal studies, ultimately accelerating the development of safer and more effective therapeutics.

Wildfire smoke poses a growing public health threat, with harmful pollutants like PM2.5 linked to respiratory and cardiovascular issues. This blog explores the health impacts of wildfire smoke, highlights recent research advancements, and showcases innovative tools like DSI’s inhalation exposure systems and telemetry solutions. Discover how these technologies are helping researchers uncover the mechanisms behind smoke-related health risks and develop interventions to protect vulnerable populations.

The integration of behavioral telemetry and organoid research is transforming neuroscience and biomedical science by linking cellular models with complex biological behaviors.

Revolutionize your diabetes research with DSI’s continuous glucose telemetry system. This innovative technology enables real-time, long-term glucose monitoring in animal models, offering stress-free, comprehensive data collection. By bridging preclinical and clinical research, it supports breakthroughs in glycemic control and translational therapies. Learn how it’s shaping the future of diabetes treatments.

Organoid technology is poised to revolutionize the development of brain-controlled prosthetics. By bridging the gap between the body’s central nervous system and a synthetic device, research with neural organoids could lead to the development of prosthetics capable of real-time interaction with the human brain through closed-loop feedback systems. Multielectrode array technology (also called “microelectrode array” or “MEA”) from Multi Channel Systems is ideally suited for studying this complex interaction and developing innovations in prosthetic research.

PTSD affects millions, with varied trauma responses complicating treatment. Advanced research tools, including telemetry and behavioral systems, help uncover physiological and behavioral insights, paving the way for personalized therapies. Studies highlight sex-specific stress adaptations, novel drug targets, and physiological biomarkers, advancing understanding and treatment options for this complex disorder. Continued innovation is key to improving PTSD care.

Unlike traditional MEA recordings that can only measure field potentials, the IntraCell uses a laser to precisely optoporate cardiomyocytes underneath each electrode.